| Literature DB >> 32400257 |
Muhammad Waseem Aslam1, Seng Fong Lau1, Chelly Sze Lee Chin1, Nur Indah Ahmad2, Nor-Alimah Rahman1, Krishnammah Kuppusamy2, Sharina Omar2, Rozanaliza Radzi1.
Abstract
OBJECTIVES: This retrospective study aimed to describe clinical manifestations, diagnostic options, radiological features, therapeutic plans and outcomes for cats infected with Rhodococcus equi.Entities:
Keywords: Rhodococcus equi; alveolar–interstitial; cutaneous; pulmonary
Year: 2019 PMID: 32400257 PMCID: PMC7206563 DOI: 10.1177/1098612X19886395
Source DB: PubMed Journal: J Feline Med Surg ISSN: 1098-612X Impact factor: 2.015
Figure 1Age distribution of the cats
Clinical signs of 40 cats infected with Rhodococcus equi
| Clinical signs | n (%) |
|---|---|
| Dyspnoea/respiratory distress | 35 (87.5) |
| Abdominal breathing | 26 (65.0) |
| Anorexia/hyporexia | 26 (65.0) |
| Tachypnoea | 19 (47.5) |
| Dehydration | 14 (35.0) |
| Open-mouth breathing | 13 (32.5) |
| Crackles on thoracic auscultation | 11 (27.5) |
| Lethargy | 8 (20.0) |
| Weight loss | 7 (17.5) |
| Coughing | 5 (12.5) |
| Pyrexia | 5 (12.5) |
| Cutaneous lesions | 4 (10) |
| Ocular/nasal discharge | 2 (5.0) |
| Diarrhoea | 2 (5.0) |
| Cyanotic mucous membranes | 1 (2.5) |
| Vomiting | 1 (2.5) |
Physiological, biochemical and haematological parameters of 36 cats infected with Rhodococcus equi
| Parameters (number of samples) | Normal reference range | Mean ± SE | Median | n (%) with value > upper RL | n (%) with value < upper RL |
|---|---|---|---|---|---|
| Body temperature (°C) (n = 35) | 38–39 | 38.7 ± 0.15 | 38.8 | 12 (34.3) | 7 (20) |
| PCV (l/l) (n = 36) | 0.24–0.45 | 0.295 ± 0.009 | 0.3 | 0 (0) | 4 (11.1) |
| CWCC (×109/l) (n = 36) | 5.50–19.5 | 31.25 ± 4.268 | 22.15 | 21 (58.3) | 0 (0) |
| Segmented neutrophils (×109/l) (n = 36) | 2.50–12.5 | 23.57 ± 3.290 | 14.97 | 24 (66.7) | 0 (0) |
| Band neutrophils (×109/l) (n = 36) | <0.30 | 0.992 ± 0.184 | 0.585 | 30 (83.3) | 0 (0) |
| Lymphocytes (×109/l) (n = 36) | 1.5–7.0 | 4.150 ± 0.734 | 3.02 | 4 (11.1) | 7 (19.4) |
| Monocytes (×109/l) (n = 36) | 0.20–0.80 | 1.434 ± 0.230 | 0.94 | 21 (58.3) | 0 (0) |
| Eosinophils (×109/l) (n = 31) | 0.1–1.5 | 1.294 ± 0.229 | 0.98 | 11 (35.4) | 0 (0) |
| Platelets (×109/l) (n = 36) | 300–700 | 321.7 ± 39.65 | 266 | 4 (11.1) | 20 (55.5) |
| Na+ (mmol/l) (n = 30) | 146–156 | 149.5 ± 0.833 | 150.4 | 2 (6.7) | 4 (13.3) |
| K+ (mmol/l) (n = 30) | 3.90–5.50 | 05.00 ± 0.159 | 4.85 | 6 (20) | 2 (6.7) |
| Cl– (mmol/l) (n = 30) | 110–132 | 111.7 ± 1.041 | 113.05 | 0 (0) | 6 (20) |
| Phosphorus (mmol/l) (n = 3) | 1.10–2.80 | 03.44 ± 0.311 | 3.28 | 3 (100) | 0 (0) |
| Urea (mmol/l) (n = 35) | 3.1–10.0 | 8.766 ± 0.870 | 7.8 | 8 (22.9) | 0 (0) |
| Creatinine (µmol/l) (n = 35) | 60–193 | 90.31 ± 7.755 | 82 | 0 (0) | 6 (17.1) |
| TBIL (µmol/l) (n = 2) | 1.7–17.0 | 1.305 ± 0.405 | 1.305 | 0 (0) | 1 (50) |
| ALT (U/l) (n = 35) | 10–90 | 49.43 ± 5.393 | 41 | 2 (5.7) | 0 (0) |
| ALP (U/l) (n = 9) | <80 | 43.44 ± 18.57 | 23 | 2 (22.2) | 0 (0) |
| GGT (U/l) (n = 2) | <6.0 | 13.50 ± 08.50 | 13.5 | 1 (50) | 0 (0) |
| CK (U/l) (n = 2) | <300 | 376.0 ± 25.00 | 376 | 2 (100) | 0 (0) |
| AST (U/l) (n = 2) | <60.0 | 261.5 ± 89.50 | 261.5 | 2 (100) | 0 (0) |
| TP (g/l) (n = 36) | 55–75 | 78.49 ± 1.768 | 79.15 | 22 (61.1) | 0 (0) |
| Albumin (g/l) (n = 36) | 25–40 | 28.34 ± 0.849 | 26.9 | 1 (2.8) | 8 (22.2) |
| Globulin (g/l) (n = 36) | 25–45 | 50.14 ± 1.463 | 48.8 | 23 (63.8) | 0 (0) |
| A:G (n = 36) | 0.5–1.4 | 0.577 ± 0.022 | 0.6 | 0 (0) | 14 (38.9) |
RL = reference limit; PCV = packed cell volume; CWCC = complete white cell count; TBIL = total bilirubin; ALT = alanine transaminase; ALP = alkaline phosphatase; GGT = gamma glutamyl transferase; CK = creatine kinase; AST = aspartate transaminase; TP = total protein; A:G = albumin:globulin ratio
Summary of pathologies and outcomes in a maximum of 40 cases of cats infected with Rhodococcus equi
| Parameter (total number of cats) | n (%) |
|---|---|
| Pleural effusion (n = 36) | 32 (88.9) |
| Hepatomegaly (n = 40) | 30 (75) |
| Thoracic lymphadenopathy (n = 36) | 15 (41.7) |
| Atelectasis of any lung lobe (n = 36) | 13 (36.1) |
| Consolidation of any lung lobe (n = 36) | 11 (30.6) |
| Cavitary or mass opacity lesion(s) (n = 36) | 10 (27.8) |
| Pneumothorax (n = 36) | 6 (16.7) |
| Died (n = 40) | 23 (57.5) |
| Recovered (n = 40) | 13 (32.5) |
| Euthanased (n = 40) | 4 (10) |
| Total dead cases (n = 40) | 27 (67.5) |
Figure 2Thoracic radiographs of four cats showing different types of pathologies. Enlargement of the retrosternal lymph node (white arrow) was seen in (b–d) and hepatomegaly (white star) was noted in all four cats. (a) Pleural effusion is indicated by an arrow and alveolar–interstitial pattern of the lungs with air pocket/pneumatocoele below the level of accessory lung lobe. (b) Pneumothorax, cavitary lesion in mid thorax cranial to the diaphragm. (c) Pneumothorax with atelectasis of the the right caudal and accessory lung lobes. (d) Pneumothorax with pneumatocoele just caudal to the apex of the heart and cranial to the diaphragm
Summary of the pre- and post-thoracocentesis radiographic patterns of 36 cats infected with the pulmonary form of Rhodococcus equi
| Pre-thoracocentesis findings | Post-thoracocentesis findings | |
|---|---|---|
| Bronchial | ||
| Mild | 3 (8.3) | 11 (30.6) |
| Moderate | 1 (2.8) | 3 (8.3) |
| Severe | 0 (0) | 0 (0) |
| Alveolar | ||
| Mild | 0 (0) | 4 (11.1) |
| Moderate | 16 (44.4) | 10 (27.8) |
| Severe | 20 (55.5) | 21 (58.3) |
| Interstitial | ||
| Mild | 18 (50) | 14 (38.9) |
| Moderate | 5 (13.9) | 15 (41.7) |
| Severe | 5 (13.9) | 4 (11.1) |
| Mixed pattern | 31 (86.1) | 33 (91.7) |
| Bronchioalveolar | 2 (5.6) | 1 (2.8) |
| Alveolo–interstitial | 27 (75) | 19 (52.8) |
| Bronchointerstitial | 0 (0) | 0 (0) |
| Bronchial + Alveolar + Interstitial | 2 (5.6) | 13 (36.1) |
| Solitary pattern | ||
| Bronchial | 0 (0) | 0 (0) |
| Alveolar | 5 (13.9) | 1 (2.8) |
| Interstitial | 0 (0) | 0 (0) |
Values are n (%)
Figure 3(a) Light-pinkish appearance of the pleural effusion sample from a cat positive for Rhodococcus equi. (b) Gel-like pale yellow appearance of another pleural effusion sample from a cat positive for R equi
Figure 4Cytological smear from an exudate of a massive soft tissue swelling of the left forelimb. Neutrophilic pyogranulomatous inflammation was diagnosed. (a) Neutrophils with poor cytoplasmic detail encircled with a red dotted line; a second population of large-sized cells consists of macrophages with phagocytosed coccobacillus bacteria (× 400). (b) From the same cat as in (a), large macrophages containing numerous purple cocci to coccobacilli (arrows) in the cytoplasm (× 1000). (c) Similar bacterial population within neutrophils and macrophages. Degenerated neutrophils had been labelled (× 1000). (d) Phagocytosed bacteria within the foamy cytoplasm of a giant macrophage encircled with a red dotted line (× 1000)
Summary of antibiotic susceptibility tests for a maximum of 19 cases of cats infected with Rhodococcus equi
| Antibiotic (number of samples) | Disk content (µg) | Resistance status (R+I) | Susceptibility status (S) |
|---|---|---|---|
| Cephalexin (n = 14) | 30 | 100 | 0 |
| Clindamycin (n = 2) | 2 | 100 | 0 |
| Tetracycline (n = 4) | 30 | 100 | 0 |
| Metronidazole (n = 8) | 5 | 87.5 | 12.25 |
| Amoxicillin–clavulanic acid (n = 19) | 30 | 68.4 | 31.6 |
| Amoxicillin (n = 6) | 10 | 66.6 | 33.3 |
| Sulfamethoxazole/trimethoprim (n = 5) | 25 | 60 | 40 |
| Marbofloxacin (n = 16) | 5 | 25 | 75 |
| Enrofloxacin (n = 16) | 5 | 18.75 | 81.25 |
| Azithromycin (n = 4) | 15 | 0 | 100 |
| Ceftriaxone (n = 1) | 30 | 0 | 100 |
| Erythromycin (n = 3) | 15 | 0 | 100 |
| Gentamicin (n = 2) | 10 | 0 | 100 |
Summary of antibiotic(s) usage and the dose range in 37 cats infected with Rhodococcus equi
| Pre-diagnosis | Post-diagnosis | No. of cats | Outcome | Remarks | |
|---|---|---|---|---|---|
| 1 | Amoxicillin–clavulanic acid | – | 3 | 3 died | One owner refused boarding; 2 died in pre-diagnostic management |
| 2 | Amoxicillin–clavulanic acid | Azithromycin + rifampin | 3 | 2 recovered, | Of 2 recovered cats, 1 went through a course of enrofloxacin + azithromycin before presentation. Other bacteria were susceptible to azithromycin, but infection relapsed after apparent recovery of this cat, possibly because of poor compliance, and the cat died 9 weeks after initial diagnosis because of a similar presentation |
| 3 | Marbofloxacin | – | 2 | 1 recovered, | One cat died in pre-diagonstic management, while the other went through thoracotomy, and bacteria susceptible to marbofloxacin |
| 4 | Marbofloxacin | Azithromycin | 1 | 1 died | Went through thoracotomy but died within 7 days of postoperative management of infection |
| 5 | – | Gentamicin + rifampin | 1 | 1 euthanased | Owner refused post-diagnosis management |
| 6 | Marbofloxacin + metronidazole | – | 3 | 3 died | Two cats died during pre-diagnostic management; third cat died during long-term (4 weeks) management post-diagnosis |
| 7 | Marbofloxacin + metronidazole | Switched to azithromycin + rifampin | 1 | 1 recovered | Bacteria susceptible to azithromycin |
| 8 | Amoxicillin–clavulanic acid + metronidazole | Switched to azithromycin + rifampin | 8 | 5 recovered, | Of the two cats that died, 1 was FeLV positive. Infection relapsed after an apparently full recovery in 1/5 recovered cats, possibly because of poor compliance, and the cat died 10 weeks after the initial diagnosis because of a similar presentation |
| 9 | Amoxicillin–clavulanic acid + metronidazole | Switched to marbofloxacin + rifampin | 2 | 2 recovered | Bacteria was susceptible to marbofloxacin in both cases |
| 10 | Amoxicillin–clavulanic acid + metronidazole | – | 4 | 4 died | All cats died during pre-diagnostic management of infection |
| 11 | Amoxicillin–clavulanic acid + azithromycin | Rifampin added and amoxicillin–clavulanic acid stopped | 1 | 1 euthanased | Poor response to treatment during long-term management (4 weeks) |
| 12 | Amoxicillin–clavulanic acid + metronidazole + azithromycin | Rifampin added and amoxicillin–clavulanic acid and metronidazole stopped | 2 | 1 recovered, | Dead cat had a high FCoV antibody titre and a low A:G (0.5), supporting clinical signs |
| 13 | Amoxicillin–clavulanic acid + marbofloxacin + azithromycin | Rifampin added and amoxicillin–clavulanic acid stopped | 1 | 1 recovered | – |
| 14 | Amoxicillin–clavulanic acid + metronidazole + marbofloxacin | Rifampin added and amoxicillin–clavulanic acid and metronidazole stopped | 2 | 1 recovered, | Poor response to antibiotics seen in the dead cat and bacteria were resistant to marbofloxacin |
| 15 | Amoxicillin–clavulanic acid + metronidazole + marbofloxacin | Switched to azithromycin and rifampin | 1 | 1 euthanased | Poor response to antibiotics and chest tube management, although bacteria were susceptible to azithromycin |
| 16 | Amoxicillin–clavulanic acid + metronidazole + marbofloxacin | – | 1 | 1 recovered | Eight weeks of therapy and bacteria were susceptible to marbofloxacin |
| 17 | Amoxicillin–clavulanic acid + metronidazole + enrofloxacin | – | 1 | 1 died | Died during pre-diagnostic management |
Amoxicillin–clavulanic acid: 12.5–20 mg/kg q12h; metronidazole: 10–15 mg/kg (lower dosage q8h and higher dosage q12h); marbofloxacin: 2–4 mg/kg q24h (higher dosage for susceptible bacteria); enrofloxacin: 5 mg/kg q24h for a maximum of 3 days; azithromycin: 10 mg/kg q24h used for a maximum of 8 weeks; rifampin: 10 mg/kg q24h used for a maximum of 8 weeks (with on and off adverse effects in three cases, such as anorexia and vomiting possibly related to hepatotoxicity)
FeLV = feline leukaemia virus; FCoV = feline coronavirus; A:G = albumin to globulin ratio
Figure 5Therapeutic changes seen on thoracic radiographs of a cat diagnosed with pulmonary rhodococcosis. Hepatomegaly was (white star) was noted in all four radiographs. (a) Day 0a: massive pleural effusion (white arrow) with air bronchogram. (b) Day 0b: post-thoracocentesis radiograph with a reduced amount of fluid and lobar sign. (c) Day 4 radiograph showed improvement with a small amount of fluid (arrow). (d) Day 18: complete clearance of fluid from chest cavity
Figure 6Therapeutic changes seen on the thoracic radiographs of a cat diagnosed with pulmonary rhodococcosis. Hepatomegaly was (white star) was noted in all radiographs. (a) Day 0 radiograph showed retracted lung lobes with an enlarged retrosternal lymph node (white arrow). The cat was treated as an outdoor patient and was asked to attend follow-up. (b) Arrow showing pleural effusion and prominent lobar sign noted at day 10. Thoracocentesis was performed at day 10. (c,d) Post-thoracocentesis radiographs showed a reduced amount of fluid (white arrow) in the chest cavity. (e) Day 26 radiograph showed a complete clearance of fluid from the chest cavity
Figure 7(a) Presentation of a cat diagnosed with Rhodococcus equi during ultrasound-guided thoracocentesis and pleural effusion sample collection. (b) Pure growth of R equi on blood agar
Figure 8Origin locations of the cats diagnosed with Rhodococcus equi at University Veterinary Hospital (UVH), Fakulti Perubatan Veterinar (FPV) and Universiti Putra Malaysia (UPM)